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Abstract Ectopic atrial tachycardia (EAT) often resists
medical therapy, making radiofrequency catheter ablation
(RFCA) the preferred treatment. This study reviewed the
records of 35 patients who underwent electrophysiologic
studies (EPS) and 39 RFCA procedures for EAT during a
10-year period. Of the 35 patients, 10 (28%) presented with
decreased ventricular function and tachycardia-induced
cardiomyopathy (TIC). The EAT originated on the right
atrial side in 19 patients (54%) and on the left atrial side in
the remaining 16 patients (46%). The right atrial sites
included the right atrial appendage (RAA) (n = 9, 25%),
the tricuspid annulus (n = 7, 20%), and the crista termi-
nalis (n = 3). The left atrial sites included the left atrial
appendage (LAA) (n = 6, 17%), the pulmonary veins
(n = 5, 14%), the mitral annulus (n = 3), and the posterior
wall of the left atrium (n = 2). The mechanism of all EAT
probably is automaticity. All EATs could be abolished
using RFCA. Follow-up data were available for all patients
2 to 8 years after RFCA. All 35 patients remained recur-
rence free, and ventricular function improved for all 10
patients with TIC. The origin of EAT in children differed
from its origin in adults. The authors conclude that RFCA
is a safe and effective treatment option for children with
refractory EAT and should be considered early in the
course of their illness.
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Ectopic atrial tachycardia
Ectopic atrial tachycardia (EAT) is a common chronic
supraventricular tachycardia (SVT) in children [3, 5, 16]
that often resists medical therapy. Untreated, it may pro-
gress to tachycardia-induced cardiomyopathy (TIC) [4, 13],
and differentiating it from dilated cardiomyopathy is
sometimes difﬁcult.
Radiofrequency catheter ablation (RFCA) of SVT in
children has been successful, with a low risk of signiﬁcant
complications [1]. In adults, the foci of EAT often occur
along the crista terminalis [8, 18] the tricuspid annulus
[14], the ostium of the coronary sinus [9], the perinodal
region [11], and the pulmonary veins [10]. This study
aimed to assess the clinical presentation, natural history,
and treatment response of EAT in children.
Methods
Patients
We retrospectively reviewed a consecutive series of 35
patients (17 girls and 18 boys; median age, 7 years; range
5 months to 15 years) with clinically documented paroxys-
mal or incessant EAT (Table 1). All the patients had clini-
cally documented paroxysmal or incessant EAT. Patients
with multiple changing atrial tachycardia morphologies or
structural heart disease were excluded from the study. The
age at onset of EAT varied from in utero to 14 years.
Two patients with paroxysmal EAT reported palpitations.
The remaining 33 patients had no manifest symptoms.
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123Incessant tachycardia was occasionally detected at school
electrocardiographic (ECG) examination, at routine medi-
cal checks in the fetal or infant period, or during physical
examination for upper respiratory tract infections. The 33
asymptomatic patients had incessant EAT. Of the 35
patients, 10 (28%) already had decreased ventricular
function and TIC when EAT was ﬁrst diagnosed. The
patients with decreased function had shortening fractions
ranging from 20% to 27%.
Antiarrhythmic medications were used as the initial
therapy for 29 of the 35 patients, with drugs used for rate
control, which was achieved for 25 (86%) of the 29 patients
although EAT persisted. Although rate was controlled for 6
of 10 patients with TIC, EAT, left ventricle dilatation, and
decreased ventricular function persisted. Six patients or
their parents chose participation in electrophysiologic
studies (EPS) and RFCA in preference to drug treatment.
Consequently, all 35 patients underwent EPS and RFCA.
The mean duration from onset of EAT to the EPS was
2 years.
Deﬁnition
Ectopic atrial tachycardia is characterized by (1) atrial
activation originating in a small area and spreading cen-
trifugally; (2) a range of activation time less than the
tachycardia cycle length, with the ﬁrst few beats showing
progressive shortening; (3) atrioventricular block possibly
occurring in the presence of persisting SVT; (4) ventricu-
loatrial dissociation during ventricular pacing at the cycle
length of the SVT without a change in the atrial activation
sequence; and (5) typical inability to induce or terminate
tachycardia with standard pacing protocols [6, 8, 11, 14,
18]. Cardiomyopathy was deﬁned as a shortening fraction
of less than 28% or an ejection fraction of less than 45%
[4, 12, 13, 15].
Tachycardias were considered to arise from the tricuspid
or mitral annulus based on the following criteria [14]: (1)
RFCA catheter positioned in an annular location when
viewed in right and left anterior oblique ﬂuoroscopic views
with characteristic annular motion of the catheter tip and 2)
an atrioventricular ratio less than 1.
EPS and RFCA
All patients underwent EPS after providing informed writ-
ten consent. We performed EPS and RFCA with the patient
under general anesthesia using intubation and mechanical
ventilation with blood pressure monitoring from the axillary
artery. Two diagnostic 4-Fr catheters were positioned: one
in the atrium and one in the coronary sinus. If possible, a
5-Fr catheter was placed at the His bundle electrogram site.
A 7-Fr decapolar catheter (Biosense-Webster, Diamond
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123Bar, CA, USA) was used for mapping via the inferior vena
cava. We mapped during EAT using three-dimensional
mapping for all 35 patients, and ablated at the earliest
activation sites. We used the CARTO EP Navigation system
(Biosense Webster) to obtain three-dimensional mapping
during EAT in all 35 patients and ablated at the earliest
activation sites. We did not use conventional mapping.
We usually used a temperature-controlled, 4-mm-tip
ablating catheter (maximal temperature, 60C; maximal
power, 30 W) with titration of power and temperature.
Acute procedural success was deﬁned by the absence of
tachycardia or ectopy 30 min after ablation despite infu-
sion of isoproterenol and burst atrial pacing. When a left-
sided origin was suspected, access to the left atrium for
mapping and ablation was obtained transseptally using a
Brockenbrough needle.
After the procedure, patients were treated with oral
aspirin (3 mg/kg/day) for 1 month to prevent thromboem-
bolic complications. Follow-up assessment was at 1, 3, 6,
and 12 months, with clinical assessment and a 12-lead
ECG. At 3 months, 24-h monitoring and echocardiography
were performed.
Statistical Analysis
All continuous variables are expressed as mean ± standard
deviation. Comparisons between groups were performed
with an unpaired Student t test or a Mann–Whitney U test.
A p value less than 0.05 was considered statistically sig-
niﬁcant. Detailed statistical analysis between different
subgroups based on age or arrhythmia origin was limited
because of the small sample sizes.
Results
Ectopic atrial tachycardia occurred spontaneously rather
than in response to programmed extra stimulation or burst
atrial pacing in any patient. After suppression by sedation,
EAT was induced by isoproterenol infusion. A progressive
increase in atrial rate with tachycardia onset (warm-up) or a
progressive decrease before tachycardia termination (cool-
down) was observed in all cases. We mapped during EAT
and ablated at the earliest activation sites.
The distribution of EAT among the 35 patients was on
the right atrial side in 19 patients (54%) and on the left
atrial side in 16 patients (46%) (Fig. 1). The right atrial
sites included the right atrial appendage (RAA) (n = 9,
25%), the tricuspid annulus (n = 7, 20%), and the crista
terminalis (n = 3). The left atrial sites included the left
atrial appendage (LAA) (n = 6, 17%), the pulmonary veins
(n = 5, 14%), the mitral annulus (n = 3), and the posterior
wall of the left atrium (n = 2). We used a Brockenbrough
needle to enter the left atrium transseptally in 16 patients
with EAT of left atrial origin. By contrast injection, we
identiﬁed the anatomic location of the RAA and LAA. The
origin of EAT was from the base of the triangulated
component of the appendage in nine patients and from the
tip of the appendage in six patients. There was no aneu-
rysm of the atrial appendage.
We usually used a temperature-controlled ablating
catheter with titration of power and temperature. In six
cases with an EAT origin in the RAA or LAA, the output
of radiofrequency (RF) could not be increased, so we
changed to a power-controlled model (maximal tempera-
ture, 70C; maximal power, 20 W). During RF, we used an
end-hole catheter irrigation to infuse saline near the RFCA
target site, which enabled us to achieve sufﬁcient power
(10–20 W) for successful ablation. There were no episodes
of perforation or thrombus.
In the short term, RFCA was successful for all 35
patients. Four patients had a recurrence of EAT within
1 month after RFCA. Two of the recurrences were located
in the tricuspid annulus, one near the right upper pul-
monary vein and one on the posterior wall of the left
atrium. Successful repeat ablations were achieved for all
patients who had a recurrence. Ultimately, we eliminated
all EATs. There were no complications or recurrences over
a mean follow-up period of 36 ± 5 months.
For 12 patients (34%), the initial episode of SVT
occurred before the age of 3 years (Table 2). In two cases,
EAT was detected during a medical check-up at the age of
3 months. Both patients presented with decreased ventric-
ular function. One patient had severe heart failure and
needed cardiopulmonary bypass. The EAT was resistant to
medical therapy, and rate control of the tachycardia proved
difﬁcult. For the remaining 10 patients, the duration of
observation with drugs for rate control was from 5 months
to 6 years, and EAT persisted during this time.
RAA 9
LAA  6
PV 5
CT 3
MA 3 TA 7
LAPW  2
IVC
SVC
RA LA
CS
Fig. 1 Origin of atrial tachycardia. SVC superior vena cava, IVC
inferior vena cava, RA right atrium, LA left atrium, RAA right atrial
appendage, CT crista terminalis, LAA left atrial appendage, PV
pulmonary vein, LAPW posterior wall of left atrium, TA tricuspid
annulus, MA mitral annulus
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123We performed RFCA in all 12 patients. Their age at the
procedure varied from 5 months to 6 years. In 6 of the 12
cases, EAT originated in the RAA. In 6 of 9 cases of EAT
originating from the RAA, the patients had their initial
episode before the age of 3 years (Table 3).
Of the 35 patients, 10 (28%) had already developed TIC
when EAT was diagnosed. After RFCA, all 10 patients
improved their shortening fraction from 22.8 ± 5.1% to
38.7 ± 11.7% (p\0.01), as measured by transthoracic
echocardiography. The EAT causing TIC originated in the
atrial appendage in six patients (RAA 3, LAA 3) and in the
atrioventricular annulus in four patients (tricuspid annulus
2, mitral annulus 2).
Adenosine triphosphate (ATP) was administered during
atrial tachycardias for 12 patients during EPS (mean dose,
5.2 ± 2.4 mg; range, 3–15 mg; 0.1–0.5 mg/kg). In all 12
cases, transient suppression occurred, but EAT recurred
immediately.
Discussion
Ectopic atrial tachycardia is thought to caused by rapid
discharges from an automatic atrial focus distinct from the
sinus node. Histologic studies have shown that spontaneous
activity arises from a single focus of abnormal cells. In
adults, the foci of EAT most often occur along the crista
terminalis [8, 18], the tricuspid annulus [14], the coronary
sinus ostium [9], the perinodal region [11], and the pul-
monary veins [10].
In contrast, our series of children showed that the ectopic
focus more often is located in one of the atrial appendages.
This difference in location of the ectopic focus suggests a
possibledifference inunderlyingsubstrateforEATbetween
childrenandadults.Inyoungerchildren,thefocusoftenmay
be a remnant of the original embryonic cells with abnormal
automaticity. In this regard, the RAA originates from the
primitive atrium, and the LAA is the remnant of the original
embryonic left atrium that develops during the third week of
gestation. We suggest that in children, persisting auto-
rhythmic tissue may be the source of the arrhythmia. Of 12
patientsyoungerthan3 yearsinourstudy,6(50%)hadEAT
originating from the RAA (p\0.02).
As a focus for EAT, the crista terminalis is unlikely in
children. The crista terminalis is an area of marked
anisotropy due to poor transverse cell-to-cell coupling [15].
By creating a region of slow conduction, such anisotropy
favors the development of microreentry. In addition, the
Table 2 Clinical characteristics of each group divided by the period
of initial episode of ectopic atrial tachycardia (EAT)
35 patients (M 18, F 17)
Onset Fetus to\3y1 2 3yt o\12 y 16 12 y to 7
S e x M4 M8 M6
F8 F8 F1
Clinical
presentation
Incessant 12 Incessant 16 Incessant 5
Paroxysmal 2
TIC 3 7 0
Site of EAT RAA 6 RAA 2 RAA 1
TA 1 TA 4 TA 2
MA 2 MA 1
LAA 1 LAA 4 LAA 1
PV 1 PV 3 PV 1
LAPW 1 LAPW 1
CT 1 CT 2
TIC tachycardia-induced cardiomyopathy, M male, F female, RAA
right atrial appendage, TA tricuspid annulus, MA mitral annulus, LAA
left atrial appendage, PV pulmonary vein, LAPW posterior wall of left
atrium, CT crista terminalis
Table 3 Clinical characteristics of each group divided by the origin of ectopic atrial tachycardia (EAT)
Site of EAT 35 patients (M 18, F 17)
RAA CT TA MA LAA PV LAPW
9 37 365 2
S e x M4 M1 M6 M1 M2 M3 M1
F5 F2 F1 F2 F4 F2 F1
Clinical presentation Incessant 8 Incessant 3 Incessant 6 Incessant 3 Incessant 6 Incessant Incessant 2
Paroxysmal 1 Paroxysmal 1 5
TIC 3 0 2 3 2 0 0
Onset
Fetus to\3 y 6 01 211 1
3yt o\1 2 y 2 14 143 1
12 y– 1 2 2 0 1 1 0
RAA right atrial appendage, CT crista terminalis, TA tricuspid annulus, MA mitral annulus, LAA left atrial appendage, PV pulmonary vein, LAPW
posterior wall of left atrium, M male, F female, TIC tachycardia-induced cardiomyopathy
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123normal sinus pacemaker complex is distributed along the
long axis of the crista terminalis [2]. Hence, cells with
spontaneous automaticity are to be found in this region. In
our study, patients with crista terminalis-related EAT were
older than 7 years, suggesting that the substrate of EAT
originating in the crista terminalis might be acquired with
age.
Adenosine-sensitive and microreentrant atrial tachycar-
dias have been reported [7], with origins in the perinodal
region and atrioventricular valve annulus in adults. The
atrioventricular annulus (tricuspid annulus, mitral annulus)
was the usual origin for EAT in our study, the mechanism
being automaticity, not reentry. In 9 of 10 patients, EAT
originated from a site in the free wall of the tricuspid
annulus or mitral annulus (Fig. 1). The one exception arose
from the tricuspid posterior septal region.
Warm-up and cool-down phenomena favor an automatic
mechanism. Tachycardia could not be initiated or termi-
nated with programmed electrical stimulation in any of our
cases. Administration of ATP transiently suppressed EAT,
but it quickly recurred. These ﬁndings support our view
that the mechanism of EAT in our patients was most likely
automaticity.
RFCA
Because of the lower ﬂow at the tip than at the base of the
RAA or LAA, we used a lower temperature and power at
the tip. Irrigation RFCA appears to be an effective proce-
dure for EAT of RAA [7] or LAA origin, but its use is not
approved in our institution. As an alternative, we per-
formed the RF procedure with a power-controlled model or
infused saline during RF near the ablation site. Because the
atrial appendage wall is very thin, perforation with cardiac
tamponade is a signiﬁcant risk, so catheter manipulation
and ablation require great care. We were able to eliminate
EAT originating from the atrial appendages during one
session without complications.
Systolic dysfunction associated with chronic tachyar-
rhythmias is known as TIC [4, 13]. Of our 35 patients, 10
(28%) presented with decreased ventricular function and
TIC, an incidence similar to that reported in the literature
[3, 5]. Complication of EAT by TIC was more often
observed in children than in adults. Medi et al. [13]
reported a 10% incidence of TIC with EAT in adults.
Children with EAT are less likely to be aware of palpita-
tions and tachycardia episodes.
In our study, 33 of the 35 patients had no typical com-
plaints when EAT was diagnosed, and their EAT was
incessant. In the two patients who reported palpitations, the
EAT was paroxysmal. With successful elimination of the
tachycardia substrate, the patients experienced signiﬁcant
improvement in their left ventricular ejection fraction. This
emphasizes the need to treat these patients aggressively to
restore normal sinus rhythm and maintain ventricular
function. Ectopic atrial tachycardia complicated by TIC
commonly originates in the atrial appendages or atrioven-
tricular annulus, and this association may reﬂect the
incessant behavior of tachycardia originating in these
locations.
A higher rate of spontaneous resolution in younger
patients (\3 years) comparedwith olderpatients (C3 years)
has been reported [16]. In our study, 12 patients (34%) had
their initial episode of SVT before the age of 3 years. We
performed RFCA in 12 cases. The age at the RFCA proce-
dure varied from 5 months to 6 years. Spontaneous resolu-
tion of tachycardia was not uncommon in our study.
Although Blaufox et al. [1] supported the use of RFCA
by experienced physicians for selected infants, the pre-
dominant view is that a favorable risk-to-beneﬁt ratio may
not exist for younger children. Additionally, there is con-
cern regarding the late enlargement of RF lesions located in
the immature atrial myocardium of younger children [17].
Although cryoablation appears to be an effective and safe
procedure for children, its use is not approved in Japan, so
it was unavailable for these patients.
All efforts should be made to treat younger children
medically, at least through infancy. However, if they
experience a cardiomyopathy, we recommend EPS with
consideration of RFCA. In children, EAT is unlikely to
resolve spontaneously, and antiarrhythmics are frequently
ineffective. Because RFCA has been used successfully and
safely, it should be considered early in the course of
treatment, especially if there is an associated TIC.
Conclusion
The origin of EAT in children differed from that in adults.
We conclude that RFCA is a safe and effective treatment
option for children with refractory EAT and should be
considered early in the course of their illness.
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